Raggruppamento Primario: Malattie Neuromuscolari

Filtra

Data

Nusinersen efficacy data for 24-month in type 2 and 3 spinal muscular atrophy

Technology outcome measures in neuromuscular disorders: A systematic review

Revised upper limb module in type II and III spinal muscular atrophy: 24-month changes

Assessing Cognitive Function in Neuromuscular Diseases: A Pilot Study in a Sample of Children and Adolescents

Longitudinal Motor Functional Outcomes and Magnetic Resonance Imaging Patterns of Muscle Involvement in Upper Limbs in Duchenne Muscular Dystrophy

Hepatobiliary disease in XLMTM: a common comorbidity with potential impact on treatment strategies

Motor function in type 2 and 3 SMA patients treated with Nusinersen: a critical review and meta-analysis

SMA-miRs (miR-181a-5p, -324-5p, and -451a) are overexpressed in spinal muscular atrophy skeletal muscle and serum samples

Different trajectories in upper limb and gross motor function in spinal muscular atrophy

Age related treatment effect in type II Spinal Muscular Atrophy pediatric patients treated with nusinersen

Torna in alto